NPM: Bone Grafting Material, Animal Source
What it covers
A animal-source bone grafting material is a naturally-derived device, such as collagen, intended to fill, augment, or reconstruct periodontal defects and or bony defects of the upper or lower jaw.
FDA’s definition of product code NPM, from the Product Classification database.
FDA flags NPM devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K260096 | Wishbone HAE | Wishbone SA | Oct 9, 2026 | Traditional |
| K254210 | REBOHIL (BGM-1, BGM-2, BGM-3, BGM-4, BGM-5) | Hyundai Bioland Co., Ltd. | Sep 25, 2026 | Traditional |
| K253723 | BOSS | Medpark Co., Ltd. | Jun 16, 2026 | Traditional |
| K251786 | Geistlich Bio-Oss®; Geistlich Bio-Oss Pen® | Geistlich Pharma AG | Jul 11, 2025 | Special |
| K251613 | SwissGraft X | Geistlich Pharma AG | Jun 26, 2025 | Special |
| K242510 | Geistlich Bio-Flow® | Geistlich Pharma AG | Mar 7, 2025 | Traditional |
| K240133 | Xenograft Bovine Bone Particulate | Collagen Solutions, LLC | Aug 16, 2024 | Traditional |
| K230305 | THE Graft Collagen | Purgo Biologics, Inc. | Jul 24, 2024 | Traditional |
| K240661 | Geistlich Bio-Oss® | Geistlich Pharma AG | Jul 12, 2024 | Traditional |
| K231672 | S1 | Medpark Co., Ltd. | Oct 13, 2023 | Traditional |
Clearances by year
37 NPM 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 3 | 269 |
| 2025 | 3 | 30 |
| 2024 | 3 | 211 |
| 2023 | 2 | 198 |
| 2021 | 2 | 167 |
| 2020 | 3 | 231 |
| 2018 | 2 | 312 |
| 2017 | 5 | 191 |
| 2016 | 1 | 422 |
| 2015 | 4 | 349 |
| 2014 | 2 | 319 |
| 2013 | 2 | 295 |
| 2012 | 2 | 147 |
| 2011 | 3 | 112 |
Who submits
19 applicants cleared a NPM device since 2011. 59% of the clearances went to applicants in United States, then South Korea (19%), Switzerland (14%) and Belgium (5%). By type: Traditional 84%, Abbreviated 11% and Special 5%.
| Applicant | Clearances since 2011 |
|---|---|
| Geistlich Pharma AG | 8 |
| Collagen Matrix, Inc. | 6 |
| Purgo Biologics, Inc. | 3 |
| Medpark Co., Ltd. | 2 |
| Nibec Co., Ltd. | 2 |
| Sigmagraft, Inc. | 2 |
| Wishbone SA | 2 |
| Chiyewon | 1 |
How FDA classifies it
(1) Class II (special controls) for bone grafting materials that do not contain a drug that is a therapeutic biologic. The special control is FDA's “Class II Special Controls Guidance Document: Dental Bone Grafting Material Devices.” (See § 872.1(e) for the availability of this guidance document.)
(2) Class III (premarket approval) for bone grafting materials that contain a drug that is a therapeutic biologic. Bone grafting materials that contain a drug that is a therapeutic biologic, such as biological response modifiers, require premarket approval.
From 21 CFR 872.3930. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 872.3930 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent NPM clearances declared.
Ask about NPM
Questions about NPM
What is FDA product code NPM?
Product code NPM, “Bone Grafting Material, Animal Source” in FDA's classification database, is a Class II device type under 21 CFR 872.3930 (bone grafting material), reviewed by FDA's Dental panel. FDA's 510(k) database lists 42 clearances under NPM, 37 of them since 2011.
How many 510(k) clearances are there under NPM?
FDA’s 510(k) database listed 42 clearances under NPM as of Oct 29, 2026, 37 of them decided since 2011; the most recent decision was Oct 9, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a NPM 510(k)?
For the 6 NPM clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 200 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most NPM clearances?
Since 2011: Geistlich Pharma AG (8), Collagen Matrix, Inc. (6), Purgo Biologics, Inc. (3), Medpark Co., Ltd. (2) and Nibec Co., Ltd. (2). 19 applicants have cleared a NPM device in that time.